Check our latest news and where we are going to be soon.
Biohope at American Transplant Congress ATC2026.
Proud to see our team on the ground at the American Transplant Congress (ATC) 2026 in Boston! Isabel and Joshua are there representing Biohope, engaging with the transplant community, sharing insights, and exploring new collaborations around [...]
Immunobiogram® launches in Mexico thanks to a partnership between Biohope and Grupo Vanquish
Biohope Scientific Solutions for Human Health and Grupo Vanquish announce the launch of Immunobiogram® in Mexico, a milestone that marks a new step in the international expansion of this innovative immunology diagnostic solution. From this month, [...]
Biohope partners with Duraent Lifesciences to introduce Immunobiogram® in India
We are proud to partner with Duraent Lifesciences to introduce Immunobiogram® in India, scaling access through a partner-led model At Biohope, we built Immunobiogram®: a CE‑marked, patented pharmacodynamic IVD that maps a patient’s immune-cell response to [...]
National Kidney Foundation (NKF) Innovation Fund invests in Biohope
We are proud to share that the National Kidney Foundation (NKF) Innovation Fund has invested in Biohope to advance personalized medicine in kidney transplantation. This investment will support further clinical validation and progress toward U.S. regulatory approval [...]
Biohope Welcomes Virginia González as New Chief Executive Officer
Biohope is glad to announce the appointment of Virginia González as its new Chief Executive Officer, marking an important milestone in the company’s evolution after more than ten years of growth and scientific consolidation. As CEO, Virginia [...]
Biohope Announces Collaboration to Advance Immunobiogram for Renal Transplant
Madrid, Spain, November 3rd, 2025 – Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has signed a know-how agreement with Mayo Clinic, a global leader in medical research and patient [...]
Biohope Publishes New Pilot Study in Rheumatoid Arthritis, Opening the Path to a Novel Predictive Test
Biohope is proud to announce the publication of its latest scientific contribution in PLOS ONE: “Precision Medicine in Rheumatoid Arthritis: Evaluation of a New Approach to Predict Clinical Response to Methotrexate in Patients with Early Rheumatoid [...]
Biohope presents the results of the BIOTRAIM study at the WTC’25 and they are selected among the most relevant abstracts in kidney transplantation
Biohope participated in the World Transplant Congress (WTC 2025) in San Francisco from 3 to 6 August 2025. We presented two oral communications on the results of the BIOTRAIM study. The WTC 2025 was the most [...]
Biohope is pleased to welcome Andrea Espigares Correa, MD, as our new Clinical Science Director
Andrea brings broad clinical and research experience, with a strong foundation in internal medicine and a deep commitment to advancing patient-centered innovation. Her work spans various healthcare systems and therapeutic areas, contributing to a holistic understanding of [...]
Biohope Welcomes Joshua Lee as Medical Director for US
Biohope is delighted to announce the appointment of Joshua Lee, MD, as the Medical Director for US. He has a diverse background in medical affairs and product launch in Cardiovascular, Nephrology, and Transplant therapeutic areas. With 14 [...]
